{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:13:53Z","timestamp":1783566833846,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ejso.2016.02.017","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T06:23:52Z","timestamp":1456381432000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM \u2013 Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor"],"prefix":"10.1016","volume":"42","author":[{"given":"J.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Alexandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Cipriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Falc\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6661-4468","authenticated-orcid":false,"given":"M.","family":"Ser\u00f4dio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Tralh\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Prado e Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Castro e Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2016.02.017_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.ejso.2016.02.017_bib2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1634\/theoncologist.2012-0121","article-title":"The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus","volume":"17","author":"Adam","year":"2012","journal-title":"Oncology"},{"issue":"14","key":"10.1016\/j.ejso.2016.02.017_bib3","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2007.07.017","article-title":"Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group","volume":"43","author":"Nordlinger","year":"2007","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.017_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"issue":"22","key":"10.1016\/j.ejso.2016.02.017_bib5","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"9617","key":"10.1016\/j.ejso.2016.02.017_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"33","key":"10.1016\/j.ejso.2016.02.017_bib7","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2016.02.017_bib8","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","article-title":"Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases","volume":"17","author":"Kishi","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.02.017_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2016.02.017_bib10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"10.1016\/j.ejso.2016.02.017_bib11","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.017_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2016.02.017_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/hpb.12047","article-title":"Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab","volume":"15","author":"Hubert","year":"2013","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.ejso.2016.02.017_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ejso.2016.02.017_bib15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ejso.2014.06.011","article-title":"Liver failure in patients treated with chemotherapy for colorectal liver metastases: role of chronic disease scores in patients undergoing major liver surgery. A case-matched analysis","volume":"40","author":"Ratti","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2016.02.017_bib16","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00268-009-0204-2","article-title":"Intermittent pringle maneuver and hepatic function: perioperative monitoring by noninvasive ICG-clearance","volume":"33","author":"Tralh\u00e3o","year":"2009","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2016.02.017_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2016.02.017_bib18","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","article-title":"The \u201c50-50 criteria\u201d on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy","volume":"242","author":"Balzan","year":"2005","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.017_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2016.02.017_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.surg.2010.12.002","article-title":"Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery","volume":"149","author":"Koch","year":"2011","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.ejso.2016.02.017_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1477-2574.2011.00319.x","article-title":"Post-hepatectomy haemorrhage: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"13","author":"Rahbari","year":"2011","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.ejso.2016.02.017_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ejso.2016.02.017_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.surg.2013.07.022","article-title":"Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases","volume":"155","author":"Reissfelder","year":"2014","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.017_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0b013e3182a6183e","article-title":"Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival","volume":"258","author":"Vigan\u00f2","year":"2013","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.017_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1477-2574.2012.00454.x","article-title":"Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity","volume":"14","author":"Pilgrim","year":"2012","journal-title":"HPB \u2013 Off J Int Hepato Pancreato Biliary Assoc"},{"issue":"1","key":"10.1016\/j.ejso.2016.02.017_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2016.02.017_bib27","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1007\/s00268-012-1565-5","article-title":"Prolonged portal triad clamping increases postoperative sepsis after major hepatectomy in patients with sinusoidal obstruction syndrome and\/or steatohepatitis","volume":"36","author":"Narita","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2016.02.017_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00595-010-4414-x","article-title":"Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization","author":"Narita","year":"2011","journal-title":"Surg Today"},{"issue":"2","key":"10.1016\/j.ejso.2016.02.017_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","article-title":"Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy","volume":"18","author":"Tamandl","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.02.017_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12885-015-1247-4","article-title":"Oxaliplatin toxicity presenting as a liver nodule \u2013 case report","volume":"15","author":"Alexandrino","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.017_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)","volume":"4","author":"Fan","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.017_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","article-title":"Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans","volume":"10","author":"Rubbia-Brandt","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.017_bib33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jhep.2011.10.023","article-title":"Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation","volume":"56","author":"Agostini","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"January","key":"10.1016\/j.ejso.2016.02.017_bib34","first-page":"1","article-title":"Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer","volume":"108","author":"Vreuls","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.017_bib35","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2016.02.017_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.critrevonc.2010.07.012","article-title":"Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer","author":"Chua","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.017_bib37","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1245\/s10434-013-2915-8","article-title":"Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases","volume":"20","author":"Van Den Broek","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2016.02.017_bib38","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2016.02.017_bib39","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1245\/s10434-010-1074-4","article-title":"Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis","volume":"17","author":"Takamoto","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.02.017_bib40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.7863\/jum.2011.30.11.1593","article-title":"Acoustic radiation force impulse elastography and contrast-enhanced sonography of sinusoidal obstructive syndrome (Veno-occlusive disease): preliminary results","volume":"30","author":"Fontanilla","year":"2011","journal-title":"J\u00a0Ultrasound Med"},{"issue":"8","key":"10.1016\/j.ejso.2016.02.017_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0072306","article-title":"Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome","volume":"8","author":"Fung","year":"2013","journal-title":"PLoS One"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T03:31:20Z","timestamp":1654399880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0748798316001128"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.02.017","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM \u2013 Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}